NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.38
-2.09 (-10.21%)
At close: Apr 1, 2025, 4:00 PM
18.78
+0.40 (2.18%)
After-hours: Apr 1, 2025, 5:29 PM EDT

NAMS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-241.6-176.94-22.63-41.79-5.75
Depreciation & Amortization
0.110.050.010.010
Other Amortization
-0.23--0.16-
Asset Writedown & Restructuring Costs
--87.22-
Stock-Based Compensation
33.6224.574.121.24-
Other Operating Activities
82.25.2310.8-0.820.31
Change in Accounts Payable
-12.955.074.816.560.83
Change in Unearned Revenue
-3.95-8.7118.43--
Change in Other Net Operating Assets
-15.779.5-12.86-2.09-1.36
Operating Cash Flow
-158.56-141.2210.67-29.51-5.97
Capital Expenditures
-0.67-0.02-0.22-0.02-0.01
Investment in Securities
-62.18----
Investing Cash Flow
-62.85-0.02-0.22-0.02-0.01
Short-Term Debt Issued
--0.75-11.32
Total Debt Issued
--0.75-11.32
Net Debt Issued (Repaid)
--0.75-11.32
Issuance of Common Stock
661.048.91396.95--
Repurchase of Common Stock
-0.99----
Other Financing Activities
-0.54--5.79--
Financing Cash Flow
659.518.91391.9184.711.32
Foreign Exchange Rate Adjustments
-6.85.055.25-4.680.02
Net Cash Flow
431.29-127.28407.650.495.36
Free Cash Flow
-159.24-141.2410.44-29.54-5.98
Free Cash Flow Margin
-349.49%-1002.43%10.17%--
Free Cash Flow Per Share
-1.69-1.720.55-2.69-1.20
Cash Interest Paid
--0.28--
Cash Income Tax Paid
00.03---
Levered Free Cash Flow
-43.39-7222.7-15.94-
Unlevered Free Cash Flow
-43.17-7222.88-15.84-
Change in Net Working Capital
-33.95-17.76-21.14-4.83-
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q